NO972615D0 - Benzimidazolderivater - Google Patents

Benzimidazolderivater

Info

Publication number
NO972615D0
NO972615D0 NO972615A NO972615A NO972615D0 NO 972615 D0 NO972615 D0 NO 972615D0 NO 972615 A NO972615 A NO 972615A NO 972615 A NO972615 A NO 972615A NO 972615 D0 NO972615 D0 NO 972615D0
Authority
NO
Norway
Prior art keywords
paf
nitrogen atom
benzimidazole
amelioration
hydrates
Prior art date
Application number
NO972615A
Other languages
English (en)
Other versions
NO972615L (no
Inventor
Mark Whittaker
Andrew Miller
Stephen Arthur Bowles
Original Assignee
British Bio Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909017878A external-priority patent/GB9017878D0/en
Priority claimed from GB909018040A external-priority patent/GB9018040D0/en
Priority claimed from GB919112214A external-priority patent/GB9112214D0/en
Application filed by British Bio Technology filed Critical British Bio Technology
Publication of NO972615D0 publication Critical patent/NO972615D0/no
Publication of NO972615L publication Critical patent/NO972615L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/08Radicals containing only hydrogen and carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO972615A 1990-08-15 1997-06-06 Benzimidazolderivater NO972615L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB909017878A GB9017878D0 (en) 1990-08-15 1990-08-15 Compounds
GB909018040A GB9018040D0 (en) 1990-08-16 1990-08-16 Compounds
GB919112214A GB9112214D0 (en) 1991-06-06 1991-06-06 Compounds
PCT/GB1991/001392 WO1992003423A1 (en) 1990-08-15 1991-08-15 Benzimidazole derivatives, process for their preparation and application

Publications (2)

Publication Number Publication Date
NO972615D0 true NO972615D0 (no) 1997-06-06
NO972615L NO972615L (no) 1997-06-06

Family

ID=27265233

Family Applications (2)

Application Number Title Priority Date Filing Date
NO930498A NO301228B1 (no) 1990-08-15 1993-02-12 Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolderivater, samt mellomproduktforbindelser
NO972615A NO972615L (no) 1990-08-15 1997-06-06 Benzimidazolderivater

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO930498A NO301228B1 (no) 1990-08-15 1993-02-12 Analogifremgangsmåte for fremstilling av terapeutisk aktive benzimidazolderivater, samt mellomproduktforbindelser

Country Status (18)

Country Link
US (1) US5180723A (no)
EP (1) EP0543858B1 (no)
JP (2) JP2976004B2 (no)
KR (1) KR0185959B1 (no)
AT (1) ATE198197T1 (no)
AU (2) AU655595B2 (no)
CA (1) CA2088761C (no)
DE (1) DE69132497T2 (no)
ES (1) ES2153820T3 (no)
FI (1) FI103409B (no)
GR (1) GR3035511T3 (no)
HK (1) HK1012336A1 (no)
HU (1) HUT67289A (no)
IE (1) IE70217B1 (no)
NO (2) NO301228B1 (no)
NZ (1) NZ239409A (no)
PT (1) PT98673B (no)
WO (1) WO1992003423A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE912874A1 (en) * 1990-08-15 1992-02-26 British Bio Technology Compounds
US5274094A (en) * 1990-08-15 1993-12-28 British Bio-Technology Limited Production of heterobicyclic containing benzene sulfonamides
GB9116056D0 (en) * 1991-07-24 1991-09-11 British Bio Technology Compounds
GB9122308D0 (en) * 1991-10-21 1991-12-04 British Bio Technology Compounds
GB9200245D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
GB9200209D0 (en) * 1992-01-07 1992-02-26 British Bio Technology Compounds
GB9201755D0 (en) * 1992-01-28 1992-03-11 British Bio Technology Compounds
GB9202791D0 (en) * 1992-02-11 1992-03-25 British Bio Technology Compounds
DE4206042A1 (de) * 1992-02-27 1993-09-02 Bayer Ag Sulfonylbenzyl-substituierte imidazopyridine
DE4327256A1 (de) * 1993-08-13 1995-02-16 Bayer Ag Sulfonylbenzyl-substituierte Benzimidazole, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
GB2298138B (en) * 1993-11-10 1997-07-09 British Biotech Pharm 4-(1h-2-methylimidazo 4,5-c pyridinylmethyl)phenyl sulphonamide carboxylic acid derivatives as antagonists
GB9323162D0 (en) * 1993-11-10 1994-01-05 British Bio Technology 4-(1h-2-methylimidazo(4,5-c)pyridinylmethyl)phenylsulphonamid e derivatives as antagonists of paf
EP0775134A4 (en) 1994-08-04 1997-08-13 Synaptic Pharma Corp NEW BENZIMIDAZOLE DERIVATIVES
US5567711A (en) * 1995-04-19 1996-10-22 Abbott Laboratories Indole-3-carbonyl and indole-3-sulfonyl derivatives as platelet activating factor antagonists
GB9508748D0 (en) * 1995-04-28 1995-06-14 British Biotech Pharm Benzimidazole derivatives
ES2106682B1 (es) * 1995-09-08 1998-07-01 Uriach & Cia Sa J Nuevos derivados azo del acido 5-aminosalicilico.
ES2104513B1 (es) * 1995-10-11 1998-07-01 Uriach & Cia Sa J Nuevos derivados del acido 5-aminosalicilico.
CA2204747C (en) * 1995-09-08 2009-05-05 Elena Carceller New azo derivatives of 5-aminosalicylic acid
US6495583B1 (en) 1997-03-25 2002-12-17 Synaptic Pharmaceutical Corporation Benzimidazole derivatives
JP2003515560A (ja) * 1999-12-06 2003-05-07 スミスクライン・ビーチャム・コーポレイション トロンボポイエチン模倣物
US6858630B2 (en) 1999-12-06 2005-02-22 Smithkline Beecham Corporation Naphthimidazole derivatives and their use as thrombopoietin mimetics
ES2165803B1 (es) * 2000-04-10 2003-09-16 Uriach & Cia Sa J Nueva sal de un derivado azo del acido 5-aminosalicilico
AU2002343530A1 (en) * 2001-10-17 2003-04-28 Croda, Inc. Esters of aromatic alkoxylated alcohols and fatty carboxylic acids
TW200303742A (en) * 2001-11-21 2003-09-16 Novartis Ag Organic compounds
US20060293370A1 (en) * 2005-06-10 2006-12-28 Saunders Jeffrey O Sulfonamide compounds and uses thereof
US7829589B2 (en) * 2005-06-10 2010-11-09 Elixir Pharmaceuticals, Inc. Sulfonamide compounds and uses thereof
RU2453312C1 (ru) * 2010-11-10 2012-06-20 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" Средство, проявляющее антиагрегантную и антитромбогенную активности
SG10201609718WA (en) * 2011-11-23 2017-02-27 Cell Therapy Ltd Platelet lysate gel
GB201321735D0 (en) * 2013-12-09 2014-01-22 Ucb Pharma Sa Therapeutic Agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6715600A (no) * 1966-12-02 1968-06-04
US4612323A (en) * 1983-06-27 1986-09-16 Sumitomo Chemical Company, Limited Insecticidal and acaricidal derivatives of 1-benzylbenzimidazole
US4804658A (en) * 1986-09-15 1989-02-14 G. D. Searle & Co. Imidazopyridine derivatives and pharmaceutical compositions
US4914108A (en) * 1988-03-14 1990-04-03 G. D. Searle & Co. 5-substituted(4,5-c)imidazopyridine compounds which have useful platelet activating factor antagonistic activity
WO1989008653A1 (en) * 1988-03-15 1989-09-21 G.D. Searle & Co. 1H/3H-[4-(N,N-DICYCLOALKYL/BRANCHED-ALKYLCARBOXAMIDO)-BENZYL]IMIDAZO[4,5-c]PYRIDINES AS PAF ANTAGONISTS
GB8904174D0 (en) * 1989-02-23 1989-04-05 British Bio Technology Compounds
IL94390A (en) * 1989-05-30 1996-03-31 Merck & Co Inc The 6-membered trans-nitrogen-containing heterocycles are compressed with imidazo and pharmaceutical preparations containing them
US5157026A (en) * 1989-05-30 1992-10-20 Merck & Co., Inc. Oxo-purines as angiotensin II antagonists
IE912874A1 (en) * 1990-08-15 1992-02-26 British Bio Technology Compounds
US5274094A (en) * 1990-08-15 1993-12-28 British Bio-Technology Limited Production of heterobicyclic containing benzene sulfonamides

Also Published As

Publication number Publication date
DE69132497T2 (de) 2001-06-13
IE70217B1 (en) 1996-10-30
ES2153820T3 (es) 2001-03-16
JP2976004B2 (ja) 1999-11-10
AU8426891A (en) 1992-03-17
AU5309094A (en) 1994-03-17
FI930634A0 (fi) 1993-02-12
IE912875A1 (en) 1992-02-26
JPH11315070A (ja) 1999-11-16
GR3035511T3 (en) 2001-06-29
AU658337B2 (en) 1995-04-06
CA2088761A1 (en) 1992-02-16
HK1012336A1 (en) 1999-07-30
FI930634A (fi) 1993-04-05
FI103409B1 (fi) 1999-06-30
DE69132497D1 (de) 2001-01-25
US5180723A (en) 1993-01-19
NO930498L (no) 1993-04-14
HUT67289A (en) 1995-03-28
WO1992003423A1 (en) 1992-03-05
NZ239409A (en) 1994-05-26
AU655595B2 (en) 1995-01-05
HU9300389D0 (en) 1993-04-28
NO301228B1 (no) 1997-09-29
JPH06500316A (ja) 1994-01-13
EP0543858A1 (en) 1993-06-02
PT98673A (pt) 1992-07-31
NO972615L (no) 1997-06-06
KR930701413A (ko) 1993-06-11
PT98673B (pt) 1999-01-29
FI103409B (fi) 1999-06-30
KR0185959B1 (en) 1999-05-01
JP3120075B2 (ja) 2000-12-25
EP0543858B1 (en) 2000-12-20
ATE198197T1 (de) 2001-01-15
NO930498D0 (no) 1993-02-12
CA2088761C (en) 1999-11-16

Similar Documents

Publication Publication Date Title
NO972615D0 (no) Benzimidazolderivater
NO973981D0 (no) Benzimidazolderivater
DE69232334T2 (de) Substituierte 3-aminochinuclidine
WO2003062200A3 (en) Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists
DE59203976D1 (de) Hydantoinderivate.
DK132188A (da) Anvendelse af tetrahydrobenz(c,d)indol-6-carboxamider som anxiolytika
DE3462894D1 (de) 3-indolecarboxamide compounds
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
EA199700299A1 (ru) Азольные соединения с противогрибковой (антимикозной) активностью, применяемые для лечения людей и в ветеринарии
DE3782229T2 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE166058T1 (de) Neue verbindung, leustroducsin h, ihre herstellung und therapeutische verwendung